Background: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is increasing worldwide. In contrast with many other multidrug-resistant bacteria, it is suspected that they predominantly spread within the community. The objective of this study was to assess factors associated with community-acquired colonization of ESBL (+) E. coli. Methods: We performed a matched case-control study at the Charité University Hospital Berlin between May 2011 and January 2012. Cases were defined as patients colonized with community-acquired ESBL (+) E. coli identifie
Abstract : Background: : There are considerable geographical differencesin the occurrence of extende...
A case-control study was conducted in order to identify the risk factors associated with bloodstream...
PURPOSE: Inadequate empirical therapy for severe infections caused by extended-spectrum β-lactamase-...
BACKGROUND: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is i...
Background: The prevalence of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in ...
Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalo...
Abstract Background Approximately 11% of patients colonized with extended-spectrum beta-lactamase pr...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
ABSTRACTRisk-factors for bloodstream infections caused by extended-spectrum β-lactamase (ESBL)-produ...
Background: The impact of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBL-E...
International audienceBackgroundThe impact of extended-spectrum beta-lactamase (ESBL)-producing Esch...
SummaryBackgroundThe impact of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E...
Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalo...
Abstract : Background: : There are considerable geographical differencesin the occurrence of extende...
A case-control study was conducted in order to identify the risk factors associated with bloodstream...
PURPOSE: Inadequate empirical therapy for severe infections caused by extended-spectrum β-lactamase-...
BACKGROUND: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is i...
Background: The prevalence of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in ...
Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalo...
Abstract Background Approximately 11% of patients colonized with extended-spectrum beta-lactamase pr...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
ABSTRACTRisk-factors for bloodstream infections caused by extended-spectrum β-lactamase (ESBL)-produ...
Background: The impact of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBL-E...
International audienceBackgroundThe impact of extended-spectrum beta-lactamase (ESBL)-producing Esch...
SummaryBackgroundThe impact of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E...
Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalo...
Abstract : Background: : There are considerable geographical differencesin the occurrence of extende...
A case-control study was conducted in order to identify the risk factors associated with bloodstream...
PURPOSE: Inadequate empirical therapy for severe infections caused by extended-spectrum β-lactamase-...